Purpose Adjuvant chemotherapy improves survival of patients with gastric cancer.
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) …

Across the nation, patients with locally advanced gastric cancer (LAGC) are managed with
modalities including upfront surgery (US) and perioperative chemotherapy (PCT) …

Introduction: Treatment patterns for locally advanced operable gastric and oesophageal
adenocarcinoma vary, with the optimal approach an area of debate within oncology …

AIM To provide evidence regarding the postoperative treatment of patients with T4bN1-
3M0/TxN3bM0 gastric cancer, for which guidelines have not been established. METHODS …

Despite the use of first-line therapies like fluoropyrimidine and platinum-based cytotoxic
chemotherapy, gastric cancer (GC) continues to carry a poor prognosis. Recent subgroup …

对于可切除胃癌而言, 根治性手术仍然作为治疗的核心手段, 但对于转移性胃癌而言,
手术方式的选择和手术效果需要探索. 放射治疗(以下简称放疗), 化学治疗(以下简称化疗) …

Background: No predictive markers for chemotherapy activity have been validated in gastric
cancer (GC). The potential value of class III β-tubulin (TUBB3) as biomarker for prognosis …

Adenocarcinomas of the esophagus and stomach are a major cause of cancer-related
morbidity and mortality worldwide. For patients with advanced disease, first-line …

Objective Postoperative chemotherapy with S-1 or capecitabine plus oxaliplatin is a
standard treatment for resectable gastric cancer (GC). However, survival outcomes of stage …